Sickle Cell Hemoglobin: Molecular Basis Of Sickling Phenomenon Theory And Therap

References

• Allison A. C. Properties of sickle-cell hemoglobi. Biochem. J., (Lond.) 1957; 65: 212
   PubMed Web of Science ®Google Scholar
• Birch K. M., Schutz F. Actions of cyanat. Br. J. Pharmacol. Chemother. 1946; 1: 186
   Google Scholar
• Bruning W., Holtzei A. The effect of urea on hydrophobic bonds: The critical micelle concentration of n-docecyltrimethylammonium bromide in aqueous solutions of ure. J. Am. Chem. Soc. 1961; 83: 4865
   Web of Science ®Google Scholar
• Bunn H. F. Book revie. N. Engl. J. Med. 1971; 285: 637
   Google Scholar
• Carreras-Barnes J., Diederich D. A., Grisolia S. Some comparative aspects of carbamylation of human blood and of hemoglobin with cyanate and carbamyl phosphat. Eur. J. Biochem. 1972; 27: 103
   PubMedGoogle Scholar
• Cerami A., Manning J. M. Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro. Proc. Natl. Acad. Sci. USA 1971; 68: 1180
   PubMed Web of Science ®Google Scholar
• Cerami A. Cyanate as an inhibitor of red-cell sicklin. N. Engl. J. Med. 1972; 287: 807
   PubMed Web of Science ®Google Scholar
• Chabas A., Grisolia S. Effect of carbamyl phosphate on stability of some enzymes of the urea cycle: high sensitive of glutamate dehydrogenas. FEBS Lett. 1972; 31: 25
   Google Scholar
• Charache S. Book revie. Ann Intern. Med. 1971; 75: 652
   Google Scholar
• Charache S., Milner P. F. Cyanate effect on sicklin. N. Engl. J. Med. 1972; 287: 1357
   PubMedGoogle Scholar
• Cooper M. R., Ransom J. L. Rheological properties of dextran, urea and potassium cyanate in sickle cell diseas. Proceedings of the 20th Annual Blood Symposium: Sickle Cell Disease, Wayne State University School of Medicine, Detroit, Mich., January, 20–211972, Thromb. Diath. Haemorrh. (suppl. in press, 1973)
   Google Scholar
• Crist R. D., Grisolia S., Beatis C. J., Crisolia J. Carbamylation of proteins following administration to rats of carbamyl phosphate and cyanate and effects on memor. Eur. J. Biochem. 1973; 32: 109
   PubMedGoogle Scholar
• de Furia F. G., Miller D. R., Cerami A., Manning J. M. The effects of cyanate in vitro on red blood cell metabolism and function in sickle cell anemi. J. Clin. Invest. 1972; 51: 566
   PubMed Web of Science ®Google Scholar
• Desforges J. F. Treatment of sickle cell crisi. N. Engl. J. Med. 1971; 284: 913
   PubMed Web of Science ®Google Scholar
• Diederich D. Relationship between the oxygen affinity and in vitro sickling propensity of carbamylated sickle erythrocyte. Biochem. Biophys. Res. Commun. 1972; 46: 1255
   PubMed Web of Science ®Google Scholar
• Gillette P. N., Manning J. M., Cerami A. Increased survival of cell erythrocytes after treatment in vitro with sodium cyanate, Abstrac. Blood 1971; 38: 790
   Web of Science ®Google Scholar
• Gillette P. N., Manning J. M., Cerami A. Increased survival of sickle-cell erythrocytes after treatment in vitro with sodium cyanat. Proc. Natl. Acad. Sci. USA 1971; 68: 2791
   PubMed Web of Science ®Google Scholar
• Gillette P. N., Peterson C. M., Manning J. M., Cerami A. Decrease in the hemolytic anemia of sickle cell disease after administration of sodium cyanat. J. Clin. Invest. 1972; 51: 36a
   Web of Science ®Google Scholar
• Hernandez P., Castro R., Portuondo H., Ferra M., Mendez J., Boffil V., Bopha K., Lagarde M. Utilizacion de la urea endovenosa en el tratamiento de las crisis dolorosas de la anemia de celulas falciforme. Rev. Invest. Clin. 1972; 24: 83
   PubMedGoogle Scholar
• Javid M. Urea - new use of an old agent. Reduction of intracranial and intraocular pressur. Surg. Clin. North Am. 1958; 38: 907
   PubMed Web of Science ®Google Scholar
• Javid M., Settlage P. Effect of urea on cerebrospinal fluid pressure in human subjects, Preliminary repor. JAMA 1956; 150: 943
   Google Scholar
• Kilmartin J. V., Rossi-Bemardi L. Inhibition of CO2 combination and reduction of the Bohr effect in haemoglobin chemically modified at its a amino group. Nature (Lond.) 1969; 222: 1243
   PubMed Web of Science ®Google Scholar
• Kilmartin J. V., Rossi-Bernardi L. Carbon Dioxide: Chemical Biochemical and Physiological Aspects. U.S. Government Printing Office N.A.S.A. SP-188, Washington, 73
   Google Scholar
• Kinoshita J. H. National Eye Institute, Bethesda, Maryland, private communication
   Google Scholar
• Kraus L. M., Kraus A. P. Carbamyl 'phosphate mediated inhibition of the sickling of erythrocytes in vitro. Biochem. Biophys. Res. Commun. 1971; 44: 1381
   PubMed Web of Science ®Google Scholar
• Kraus A. P., Kraus L. M. Carbamyl phosphate mediated inhibition of the sickling of erythrocyte. Abstract No. 357, XIV International Congress of Hematology, Sao PauloBrazil, July, 16–211972
   Google Scholar
• Lipp E. C., Rudders R. A., Pisciotta A. V. Oral urea therapy in sickle cell anemia, a preliminary repor. Ann. Intern Med. 1972; 76: 765
   PubMed Web of Science ®Google Scholar
• Lusher J. M., Bamhart M. I. Evaluation of oral urea in the management of sickle cell anemi. Hemoglobin and Red Cell Structure and Function, G. J. Brewer. Plenum Publishing Co., New York 1972; 303
   Google Scholar
• Lusher J. M., Bamhart M. I. Oral prophylactic urea treatment in sickle cell diseas. Proceedings of the 20th Annual Blood Symposium, Sickle Cell Disease, Detroit, Mich., January, 20–211972. Wayne State University School of Medicine, Thromb. Diath. Haemorrh. (suppl. in press, 1973)
   Google Scholar
• May A., Bellingham A. J., Huehns E. R., Beaven G. H. Effect of cyanate on sicklin. Lancet 1972; 1: 658
   PubMedGoogle Scholar
• McCurdy P. R., Mahmood L. Intravenous urea treatment of the painful crisis of sickle-cell disease - a preliminary repor. N. Engl. J. Med 1971; 285: 992
   PubMed Web of Science ®Google Scholar
• Muranda M., Etcheverry R., Becker P., Duran N., Saavedra L., Pemjean I. Evaluation terapeutica de urea oral en un caso de anemia a celulas falciforme. Rev. Med. Chil. 1972; 100: 426
   PubMedGoogle Scholar
• Murayama M., Nalbandian R. M. Sickle Cell Hemoglobin: Molecule to Man. Little, Brown and Co., Boston, Mass. 1973
   Google Scholar
• Mukerjee P., Ray A. The effect of urea on micelle formation and hydrophobic bondin. J. Phys. Chem. 1963; 67: 190
   Web of Science ®Google Scholar
• Nalbandian R. M., Henry R. L., Bamhart M. I., Camp R. F., Jr. Sickling reversed and blocked by urea in invert sugar: Optical and electron microscopy evidence. 17 September, 1970, USAMRL Report No. 895 (DDC AD No. 715250)
   Google Scholar
• Nalbandian R. M., Henry R. L., Shultz G., Camp F. R., Jr., Wolf P. L. Sickle cell crisis terminated by use of urea in invert sugar in two cases. 17 September, 1970, USAMRL Report No. 896, (DDC AD No. 721005)
   Google Scholar
• Orten J. M., Nalbandian R. M. Comparative Studies of the Binding of Urea by Hemoglobin S and A Under Varying Experimental Condition. Molecular Aspects of Sickle Cell Hemoglobin, R. M. Nalbandian. Charles C Thomas, Springfield, Ill. 1971; 117, Chap. 4
   Google Scholar
• Nalbandian R. M., Shultz G., Lusher J. M., Anderson J. W., Henry R. L. Sickle cell crisis terminated by intravenous urea in sugar solutions - a preliminary repor. Am. J. Med. Sci. 1971; 261: 309
   PubMed Web of Science ®Google Scholar
• Nalbandian R. M., Anderson J. W., Lusher J. M., Agustsson A., Henry R. L. Oral urea and the prophylactic treatment of sickle cell disease - preliminary repor. Am. J. Med. Sci. 1971; 261: 325
   PubMed Web of Science ®Google Scholar
• Nalbandian R. M., Henry R. L., Bamhart M. I., Nichols B. M., Camp F. R., Jr., Wolf P. L. Sickling reversed and blocked by urea in invert suga. Am. J. Pathol. 1971; 64: 405
   PubMed Web of Science ®Google Scholar
• Nalbandian R. M., Bamhart M. I., Henry R. L., Camp F. R., Jr. Sickle cell disease: clinical advances by the Murayama molecular hypothesi. Milit. Med. 1972; 137: 215
   PubMed Web of Science ®Google Scholar
• Nalbandian R. M., Nicholas B. M., Stehouwer E. J. Urea, urease, cyanate, and the sickling of hemoglobin S. April 28, 1972, U.S. Army Research Laboratory Report No. 978
   Google Scholar
• Nalbandian R. M., Nichols B. M., Stehouwer E. J., Camp F. R., Jr. Urea, urease, cyanate, and sicklin. Clin. Chem. 1972; 18: 961
   PubMed Web of Science ®Google Scholar
• Nalbandian R. M., Bamhart M. I., Henry R. L., Camp F. R., Jr. Sickle cell disease: Clinical advances by the Murayama molecular hypothesis. May 10, 1972, U.S. Army Medical Research Laboratory Report No. 980
   Google Scholar
• Nalbandian R. M., Camp F. R., Jr. A collected bibliography of clinical advances in sickle cell disease based on the Murayama molecular hypothesis (updated from Feb. 25, 1972). November 16, 1972, U.S. Army Medical Research Laboratory Report No. 1009
   Google Scholar
• Nalbandian R. M. The molecular basis for the treatment of sickle cell disease by ure. Proceedings of the 20th Annual Blood Symposium: Sickle Cell Disease, Wayne State University School of Medicine, Detroit, Mich., January, 20–211972, Thromb. Diath. Haemorr. (suppl. in press, 1973)
   Google Scholar
• Opio E., Barnes P. M. Intravenous urea in treatment of bone-pain crises of sickle cell disease — a double-blind stud. Lancet 1972; 2: 160
   PubMed Web of Science ®Google Scholar
• Pauling L. The hemoglobin molecule in health and diseas. Proc. Am. Philos. Soc. 1952; 96: 556
   Google Scholar
• Ponder E., Ponder R. Fragmentation of red cells and ghosts in urea solutions, with a note on electrophoresis pattern. Acta Haemat. 1954; 12: 282
   PubMed Web of Science ®Google Scholar
• Ratner B. D., Miller I. F. Interaction of urea with poly (2-hydroxyethylmeth acrylate)hydrogel. J. Polym. Sci. Part A-1. 1972; 10: 2425
   Web of Science ®Google Scholar
• Refojo M. F. Hydrophobic interaction in Poly(2-hydroxymethyl-Methacrylate) Hemogenous Hydroge. J. Polym. Sci, Part A-1 1967; 5: 3103
   PubMed Web of Science ®Google Scholar
• Scrimgeour A. W. Oral prophylactic urea treatment in sickle cell disease and problems encountere. Proceedings of the 20th Annual Blood Symposium: Sickle Cell Disease, Wayne State University School of Medicine, Detroit, Michigan, January, 20–211972, Thromb. Diath. Haemorrh. (suppl. in press, 1973)
   Google Scholar
• Segel G. B., Feig S. A., Mentzer W. C., McCaffrey R. P., Wells R., Bunn F., Shohet S. B., Nathan D. G. Effects of urea and cyanate on sickling in vitro. N. Eng. J. Med. 1972; 287: 59
   PubMed Web of Science ®Google Scholar
• Start G. R., Stein W. H., Moore S. Reactions of the cyanate present in aqueous urea with amino acids and protein. J. Biol. Chem. 1960; 235: 3177
   Web of Science ®Google Scholar
• Targino de Araujo J., Wronowski A., Climino J. S. Demonstration of Hb A1 in patients with sickle-cell anemia (Hb SS) and the synthesis of A, and S hemoglobins following administration of urea orall. Abstract No. 353, XIV International Congress of Hematology, Sao PauloBrazil, July, 16–211972
   Google Scholar
• Whitney P. L., Tanford C. Solubility of amino acids in aqueous urea solutions and its implications for the denaturation of proteins by ure. J. Biol. Chem. 1962; 237: 1735
   PubMed Web of Science ®Google Scholar